---
document_datetime: 2023-09-21 19:38:33
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/waylivra-epar-all-authorised-presentations_en.pdf
document_name: waylivra-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.787033
conversion_datetime: 2025-12-14 22:42:35.377152
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EMA Number       | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging        | Content (concentration)   | Pack size                                  |
|------------------|-------------------|------------|------------------------|---------------------------|----------------------------|---------------------------|--------------------------------------------|
| EU/1/19/1360/001 | Waylivra          | 285 mg     | Solution for injection | Subcutaneous use          | Pre-filled syringe (glass) | 1.5 ml (190mg/ml)         | 1 pre-filled syringe                       |
| EU/1/19/1360/002 | Waylivra          | 285 mg     | Solution for injection | Subcutaneous use          | Pre-filled syringe (glass) | 1.5 ml (190mg/ml)         | 4 (4 x 1) pre- filled syringes (multipack) |